Enantia to Attend BIO-Europe Spring and LSX 2026 in Lisbon

Enantia will be attending BIO-Europe Spring and LSX World Congress, two of the most important events in the European biotech ecosystem. From March 23 – 26, 2026, our team will be in Lisbon to explore new collaboration opportunities. We look forward to discussing how our expertise supports drug discovery and API development programs.

Enantia is an innovation-driven CRDMO offering a comprehensive range of services in drug discovery, API development, solid-state screening and development, and clinical GMP manufacturing.

Will you also be in Lisbon? We would be delighted to connect. Feel free to reach out through the partnering platform, contact us at info@enantia.com, or connect with us on LinkedIn to schedule a meeting.